Millions of individuals rely on effective medications to manage diseases like cancer and diabetes. For those with chronic myeloid leukemia (CML), advancements in treatment selection could ...

Protein kinase inhibitors have therefore ... shed light on TIM-063's binding to AAK1's catalytic domain, offering insights into its inhibitory mechanism. By elucidating the binding of TIM-063 ...